Quintrigen Israeli Company
Quintrigen is developing p53, a targeted anti-cancer and tumor suppressor drug.
Health Tech & Life Sciences
Alternatives
No alternatives listed yet.
Suggest an Alternative
Office Locations
Mazkeret Batya, Israel